Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4337
Abstract: We read with great interest the study by Braun and colleagues regarding the natural course of bone turnover markers (BTMs) after biochemical remission in endogenous Cushing’s syndrome (CS). In this study, the documentation of increased… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Quality of Life Research"
DOI: 10.1007/s11136-021-02850-0
Abstract: Autoimmune hepatitis (AIH) is a rare chronic liver disease. Impaired health-related quality of life (HRQL) contributes to the overall disease burden. At current, only limited data related to the impact of treatment response on HRQL… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2022.101325
Abstract: Summary Background In autoimmune hepatitis (AIH), clinical practice and treatment guidelines frequently diverge as a reflection of disease heterogeneity and challenges in achieving standardised care. We sought to explore the utility of multiparametric (mp) MR… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjad212.0780
Abstract: Ustekinumab (UST) is an effective treatment for Crohn's disease (CD) and ulcerative colitis (UC). However, some patients do not respond to conventional subcutaneous (SC) doses and lose response at follow-up. The use of maintenance intravenous… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Case Reports in Endocrinology"
DOI: 10.1155/2021/8885348
Abstract: Background. The Waterhouse–Friderichsen Syndrome (WFS) is a course of bacterial meningitis with a lethality rate that is still high today. One hallmark of the clinical course is intravascular coagulopathy. This causes hemorrhagic infarctions in the… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Behavioural Neurology"
DOI: 10.1155/2024/4393169
Abstract: People with Cushing’s disease (CD) often experience both mood/anxiety disorders and cognitive impairments that persist during long‐term biochemical remission. The relationship between persistent neurocognitive and psychiatric problems in patients with CD is not well understood.… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2024.1412046
Abstract: Background Patients with Cushing’s disease (CD) often experience slow recovery of bone mineral density (BMD), and the effectiveness of anti-osteoporosis drugs in young CD patients who have achieved biochemical remission after surgery is not well… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2025.1526625
Abstract: Introduction Long-term biochemical nonremission and long-delayed diagnosis can increase the incidence of comorbidities of acromegaly and seriously affect patients’ quality of life. To identify predictors of biochemical remission and quantify the relationship between delayed diagnosis… read more here.